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Cerebral small vessel disease (CSVD, cerebral microangiopathy) leads to dementia and stroke-like symptoms.
Lacunes, white matter lesions (WML) and microbleeds are the main pathological correlates depicted in in-vivo
imaging diagnostics. Early studies described segmental arterial wall disorganizations of small penetrating cerebral
arteries as the most pronounced underlying histopathology of lacunes. Luminal narrowing caused by
arteriolosclerosis was supposed to result in hypoperfusion with WML and infarcts.
We have used the model of spontaneously hypertensive stroke-prone rats (SHRSP) for a longitudinal study to
elucidate early histological changes in small cerebral vessels. We suggest that endothelial injuries lead to multiple
sites with blood brain barrier (BBB) leakage which cause an ongoing damage of the vessel wall and finally resulting
in vessel ruptures and microbleeds. These microbleeds together with reactive small vessel occlusions induce overt
cystic infarcts of the surrounding parenchyma. Thus, multiple endothelial leakage sites seem to be the starting
point of cerebral microangiopathy. The vascular system reacts with an activated coagulatory state to these early
endothelial injuries and by this induces the formation of stases, accumulations of erythrocytes, which represent the
earliest detectable histological peculiarity of small vessel disease in SHRSP.
In this review we focus on the meaning of the BBB breakdown in CSVD and finally discuss possible consequences
for clinicians.
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The clinical picture of cerebral small vessel disease
(CSVD) is complex since the disease develops insidiously
and its etiology is only partly understood. Limited corre-
lations between neurological symptoms, imaging diag-
nostic and pathological findings impede an early enough
diagnostic and therefore therapy. It’s obvious, however,
that an illness of rather small blood vessels leads to sub-
tle development of dementia and / or episodes of stroke-
like symptoms if neurological sensitive areas are affected
by so called strategic infarcts. Lacunes, diffuse white
matter lesions (WML, also called leukoaraiosis) and* Correspondence: stefanie.schreiber@med.ovgu.de
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reproduction in any medium, provided the ormicrobleeds are the pathognomonic pathological corre-
lates detectable with modern imaging diagnostic.
Lacunes, found in 6% to 11% of autopsied brains, are de-
fined as scars or remnants of small infarcts with a dia-
meter ranging from 3 to 20 mm predominantly found in
the basal ganglia, thalamus, pons, subcortical and cerebel-
lar white matter areas [1-3]. Their development and
pathological reasons are poorly understood. Leukoaraiosis,
i.e. diffuse WML, is still a category of hyperintensities in
magnetic resonance imaging (MRI) diagnostic with no
clearly defined histological correlate. Maybe demyelin-
ations could be a potential explanation.
More than 40 years ago Fisher described the “segmen-
tal arterial wall disorganization” of small penetrating
cerebral arteries defined by vessel enlargement due to
wall remodeling with “loss of meshwork”, “hemorraghic
extravasation” and deposits of fibrinoid material [1] as
one underlying trigger for lacunes. Due to our presental Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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vessel wall fragility with blood brain barrier (BBB) dis-
turbances, a passover of plasma resulting in small vessel
wall thickening defined as lipohyalinosis [3,4] and merging
into small perivascular bleeds with associated reactive
vessel occlusions causing acute infarcts [5].
From the current point of view the chronic small
vessel wall alterations found in CSVD comprise three
subtypes including lipohyalinosis, arteriolosclerosis and
cerebral amyloid angiopathy (CAA) [4]. Especially
arteriolosclerosis, characterized by endothelial prolife-
ration, plaque-like accumulations of plasma proteins,
lymphocytes and macrophages (microatheroma, [4]),
leads to a progressive vessel wall narrowing resulting
in a delayed blood supply with hypoperfusion of the
adjacent parenchyma possibly indicated by diffuse WML
[2,6]. CAA develops as a consequence of amyloid-β(Aβ)
protein depositions within basement membranes caused
by an age- and hypertension-related failure of Aβ elimi-
nation along perivascular lymphatic drainage pathways
and is also found in Alzheimer’s disease and mixed de-
mentia [4,6,7].
Moreover, common acute lesions found in CSVD are
cerebral microbleeds and primary intracerebral hemor-
rhages, discussed as consequence of small vessel wall
fragility converging with acute hemodynamic changes
possibly caused by fluctuations of the blood pressure
[2,8]. Microbleeds are well documented and supported
by pathological findings.
Occlusions of degenerative altered small vessels, typi-
cally found in cerebral macroangiopathy associated with
thrombotic or embolic stroke, might be a reasonable
explanation for lacunar infarcts, but those occlusions
are a rather rare event in brain autopsy of patients with
CSVD [3]. Thus, Wardlaw and colleagues supposed in a
remarkable review 10 years ago, that a breakdown of
the BBB might be, however, a much more frequent rea-
son for cerebral microangiopathy since all its histo-
pathological features seem to be caused, result in or at
least being associated with an increased vessel wall fra-
gility [3].
We have recently collected data in the model of spon-
taneously hypertensive stroke-prone rats (SHRSP) that
strikingly support the importance of an early BBB dys-
function for the development of CSVD, which will be
discussed in this review.SHRSP as animal model for CSVD
Only few animal models have been recognized to be sui-
table for describing CSVD [9,10]. Although it is unlikely
that one animal model reveals all of the histopathological
features of CSVD, SHRSP have been identified to be
the most suitable one mimicking the degenerative smallvessel changes and associated lesions found in human
CSVD [9,10].
SHRSP were obtained by selective breeding from
spontaneously hypertensive rats (SHR) for the develop-
ment of spontaneous infarcts [11-13] and exhibit an
overactivity of the renin-angiotensin-system [14], a
detectability of renin within the vascular walls [15],
an altered endothelin system [16] and an increased
sympathetic nerve activity [17] potentiated by elevated
levels of prostaglandins [18] in their sum leading to
an early development of chronic severe arterial hyper-
tension [12].
Cerebral lesions in SHRSP
SHRSP develop small lacunar-like lesions with a volume
ranging from 2 to 57 mm3, larger non-territorial infarcts
anyhow commonly distributed in specific territories
of the large cerebral arteries, rarely covering multiple
vascular territories or seen in the border zones of the
large cerebral arteries as well as territorial infarcts in
some cases affecting the whole hemisphere [5,12,19,20].
This indicates a concurrent vasculopathy of large cerebral
arteries and is supported indirectly by degenerative vessel
wall changes of large leptomeningeal arteries in SHRSP
[21]. However, regarding our own studies of SHRSP,
we excluded pathologies of the large cerebral arteries
by magnetic resonance angiography (MRA) in those
single animals who exhibited an extended territorial
infarct [5]. Thus, possibly, at least some of the large
infarcts rather develop as a consequence of multiple
confluent small infarcts emerged at different time points.
This idea is supported by a complex histopathology -
including spongy edematous grey matter with micro- and
larger cysts (comparable to the “trabeculated cavities” in
human lacunes, [1]), pale “cytolytic” neurons, neuronal
loss and tissue rarefaction, accumulated astrocytes (com-
parable to astrogliosis associated with human lacunes, [1]),
fibrinoid-eosinophilic depositions and degenerative small
vessel wall changes including enlarged perivascular spaces,
wall thickening and dilatations - marking the ischemic
cerebral lesions in SHRSP and being completely different
from those histological changes seen in infarcts resulting
from large cerebral artery pathology [19-22].
Ischemic lesions are predominately found in cortical
areas (basal ganglia and thalamus are affected secondly
commonly; [12,20]) and are associated with local cere-
bral blood flow reduction shown by MRI and single
photon emission compute tomography (SPECT) [5,20].
But also already before overt infarcts are detectable
SHRSP exhibit a decline in cortical cerebral blood flow
and protein synthesis [23]. In this regard it is important
to underline, that Fredriksson et al. nearly 20 years
ago already by Evans blue injections demonstrated a
long lasting BBB leakage characterized by abundant
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ring near to petechial hemorraghes [21].
In contrast, the exact localization and extent of WML
have been rarely investigated in SHRSP and therefore
the respective existing data is quite incomplete. Myelin
stainings show a rarefication of white matter substance
accompanied by a general volume expansion in SHRSP
with BBB leakage [21]. For the understanding of the
CSVD it would be a worthwhile experimental assign-
ment to address the question whether this histology
correlates with the extent of WML in MRI.
Pathological cascade of CSVD in SHRSP
By genetic factors SHRSP develop a vascular risk profile,
which comprises arterial hypertension, insulin resistance
and hyperinsulinemia, mixed hyperlipidemia and ele-
vated levels of free fatty acids [24]. This genetic burden
is sufficient that SHRSP develop spontaneous ischemic
lesions at an age between 8 (male) and 13 to 14 months
(female) [5,20]. But what is the beginning of this path-
ology? What changes in the cerebral small vasculature
are detectable first?
Starting a longitudinal study with around 130 SHRSP
(animal procedures were conducted after obtaining the
approval of the Animal Care Commitee of Sachsen
Anhalt; reference numbers of licences for animal test-
ing 42502-2-943, 42502-2-1148, 07/2009 & 08/2012,
Magdeburg, Sachsen-Anhalt) we were able to define
some kind of pathological cascade which is described
in the following: The small vasculature of rather juvenile
SHRSP is not distinguishable from age matched Wistar
controls. However starting from an age of 12 weeks, in
SHRSP we occasionally found in capillaries of the basal
ganglia, the hippocampus and cortical areas intraluminal
accumulations of erythrocytes (Figure 1A).
We refer to this phenomenon as stases indicating an
early microvascular dysfunction. With increasing age
the number and extent of stases increased significantly;
around an age of 28 weeks de facto all SHRSP contained
stases in their brain. Now, besides capillaries also arterioles
in the basal ganglia, hippocampal and cortical areas, but
also, however very rarely, white matter areas including
the corpus callosum were affected (Figure 1B-D; [5]).
Degenerative small vessel wall changes including arterio-
losclerosis, lipohyalinosis and an increase of the extra-
cellular matrix were first detectable at an age of about
18 weeks (Figure 2A-E). None of the SHRSP developed
CAA. Around an age of 24 weeks we observed the first
animals with mini- and microbleeds ranging in their
diameter from 50 to 300 μm and occurred in different
brain regions, whereas the basal ganglia and cortical
areas were predominantly afflicted (Figure 2F & G; [5]).
As an age-dependent phenomenon the number of
mini- and microbleeds per animal and the number ofaffected animals increased up to an age of 44 weeks.
Smaller and pronounced infarcts finally occurred at
an age of around 30 weeks [5]. Infarcts consist of out-
standing spongy areas of necrosis. Noticeable, there
was a frequently found concentric arrangement of small
hemorrhages caused by leaking erythrocytes around
occluded small vessels (Figure 2H & I) leading to a
composition of infarcted tissue and bleeds (Figure 2I;
[5,19-21]). Occasionally, the site of vessel wall rupture
was still identifiable. Therefore we conclude that mini-
and microbleeds initiate the phase of infarcts by indu-
cing reactive small vessel occlusions, and, both together
cause areas with necrotic damage, representing the
final stage of CSVD in SHRSP [5].
Stases, BBB disturbances and initial microvascular
dysfunction in SHRSP
Stases of erythrocytes are the first histological peculiarity
of CSVD in SHRSP. The considerable increase of both
number and size of the affected small vessels over time
is a clear indication, that stases are causally correlated
with the pathology of capillaries and arterioles in CSVD.
Nevertheless, instantly the question arises: What are the
underlying causes of the detected stases?
We could demonstrate, that small vessels affected by
intravasal erythrocyte accumulations exhibit deposits of
plasmaproteins including immunoglobulin G (IgG) within
their walls and within the adjacent perivascular paren-
chyma indicating associated BBB damage at already young
ages (Figure 1E & F; [5,25]).
Another important point is the fact that stases are
interwoven with aggregated thrombocytes and multimers
of the von-Willebrand factor (vWF) (Figure 1G & H; [25]).
This suggests that a local, most likely restricted coagula-
tion is one main reason for their occurrence. A vessel
wall adherent activated coagulatory state as a reaction
to endothelial injuries (Figure 1I) would therefore com-
prise a mesh, where erythrocytes aggregate. This would
also explain why stases are resistant against transcardial
perfusion performed before brain removal and histology.
Finally, passive diapedesis of single intravasal erythrocytes
from the stases into the perivascular parenchyma provide
a further support that endothelial leakages are the main
reason for stases (Figure 1B & C; [5]).
Disturbances of autoregulation of small vessel tonus
represent another possible reason that at least promotes
the formation of stases. This is reflected in constrictions
and dilatations of the vessel wall we occasionally found
in arteriolar segments with stases (Figure 1D; [5]).
All together stases seem to be an indicator for endo-
thelial injuries inducing a local restricted thrombus for-
mation. Emerging thrombi usually do not lead to a
vessel occlusion but remain restricted to the vessel wall
site showing a compromised endothelium. Despite the
Figure 1 Stases, BBB disturbances and microvascular dysfunction in SHRSP. Erythrocyte accumulations (stases) in a capillary (A, hippocampus)
and arterioles (B - D, basal ganglia) associated with endothelial injury indicated by beginning diapedesis of erythrocytes (B & C, white arrows)
and IgG-deposits within the wall of affected vessels (E & F; E, erythrocyte autofluorescence in magenta). Stases might be the consequence of
erythrocyte accumulations (G & H, white arrows) within a mesh of thrombocytes (G) and threads of the von-Willebrand-factor (vWF; H) both
activated by blood brain barrier breakdown as illustrated by wall adherence of the vWF in small vessels with IgG deposits (I). Note the disturbed
vascular tone in small vessels with stases indicated by sausage-like wall dilatations, here shown in a striatal trifurcation of arterioles (D). E is
taken from [25]. A – D Hematoxylin Eosin (HE) staining. STL - solanum tuberosum lectin used as endothelial marker, Laminin used as basement
membrane marker.
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be assumed that certain amounts of plasma still enter
the vessel wall [3]. This toxic effect over time makes the
vessel wall brashly e.g. simply by cell death of smooth
muscle cells or by accumulating plasma proteins between
the basal membranes – both described as fibrinoid
necrosis and detected as (lipo-)hyalinosis by patholo-
gists [4]. In this regard one has to consider that capil-
laries are composed only by one endothelial cell layer
framed by a basal membrane. Thus leakage of the small
vasculature may increase to an amount that locally
restricted mini- and microbleeds may occur at a stage
when blood vessels still look rather intact. This is
actually what we most frequently found in SHRSP.We did not find such a lot of vessels representing the
classical lipohyalinosis (Figure 2C). Further our data
suggest that mini- and microbleeds are accumulating
all over the brain with increasing age (the same as for
plasma protein depositions before) and more and more
small bleeds develop. This induces reactive small vessel
occlusions and necrosis of the surrounding parenchyma.
It is of course unlikely that pathological changes only
affect capillaries and arterioles. As already mentioned
leptomeningeal arteries also show segmental wall thick-
ening associated with vessel occlusions [21]. Neverthe-
less, we are convinced that BBB disturbances of small
vessels are the main pathologic initiator for the symp-
toms typical for CSVD. But if so, one could expect that
Figure 2 Degenerative small vessel wall changes, small bleeds and infarcts in SHRSP. Degenerative small vessel wall changes include
arteriolosclerosis (A & B, hippocampus), lipohyalinosis (C, basal ganglia) and thickening of the extracellular matrix (D, hippocampus & E, basal
ganglia) with associated enlarged perivascular spaces (A – C). Erythrocytes, leaking through injured small vessel walls, form perivascular bleeds
(F & G, cortex). Reactive small vessel occlusions (white asterisks) surrounded by perivascular mini- and microbleeds (H & I, cortex) with
consecutive infarcts consisting of spongy, cystic and hemorrhagic tissue (I) are the consequence and represent the final stage of cerebral small
vessel disease in SHRSP. A & B – Congo red staining, C, F - I - HE staining, D & E – Movat staining.
Schreiber et al. Experimental & Translational Stroke Medicine 2013, 5:4 Page 5 of 8
http://www.etsmjournal.com/content/5/1/4the described vascular pathology is also detectable
outside of the brain. Indeed, in SHRSP we were able
to demonstrate that accumulations of erythrocytes in
peritubular capillaries and glomerular arterioles are
also counted among the first histological changes in
the kidney. Tubular damage, various stages of glomerulo-
sclerosis and degenerative arteriolar wall changes some-
times combined with occlusions indicate an advanced
pathology of hypertensive nephropathy. These findings
defined not only the severity of structural renal damage
but also were strongly correlated with the CSVD stages in
the same rat [26]. We therefore conclude that CSVD is
part of a systemic condition, which emerges in the kidney
even earlier than in the brain.Do SHR exhibit the pathological cascade of CSVD?
Contrary to SHRSP, (stroke-resistant) SHR (SHRSR),
an animal model with polygenetic and multifactorial
inheritance of chronic arterial hypertension, including
renal factors, prostaglandin-adrenergic interactions and
abnormalities of the pituitary gland [18], develop a less
pronounced blood pressure elevation and exhibit a
significant lower incidence of spontaneous tissue “soft-
ening” and hemorrhages (about 10% during a life-span
of 14 months; [13]). However, after an additional tran-
sient occlusion of the middle cerebral artery (MCA)
SHR develop stases (“plugging of cerebral microvessels
with red blood cells”, [27]), BBB damage, single erythro-
cyte diapedesis, micro- and macrohemorrhages in the
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exhibit a territorial pattern, which does not match the
common one seen in SHRSP. Stases here might indicate
the “no-reflow-phenomenon” of the microvasculature
[27,31]. The resulting depletion of oxygen to the endothe-
lium leads to an early BBB leakage, which is exacerbated
by an at least partial reperfusion of the capillary bed. A
forced diapedesis of blood with consecutive small and
larger hemorrhages is the consequence [27,29]. Thus,
whereas the pathophysiological link between stases,
BBB breakdown and bleeds seems to be comparable
between SHRSP and SHR with transient MCA occlu-
sion, the initiation of those histopathological pheno-
mena is completely different from each other. Since the
described histopathology is rather and predominantly
induced by the large artery occlusion, the described
changes are not specific for the model of SHR. Indeed,
to our best knowledge, there are so far no investigations
of the spontaneous course and the temporal develop-
ment of microvascular changes in SHR. The sole excep-
tion from that is the ken that SHR develop spontaneous
disturbances of their BBB indicated by histology, changes
in the substantial uptake to and clearance of the cerebro-
spinal fluid and its protein composition as well as an in-
creased expression of BBB channel proteins [32-37].
Concluding, SHRSP exhibit a complex cascade of CSVD
and until now it is unclear, whether SHR develop a com-
parable natural course of microvascular dysfunction ac-
companied by histopathological phenomena exceeding
their described BBB leakage.
Conclusions
Thus, coming back to the headline of this review we
can state that the SHRSP develops overt infarcts that
mainly originate from breakdown of the BBB and not
from occluded vessels. Thrombotic occlusions of small
penetrating vessels occur only at the end of a patho-
logical cascade originated by endothelial damage. This
may have important clinical consequences. Patients
with stroke-like symptoms caused by thrombotic or
embolic occlusions of large vessels generally benefit
from an anti-thrombotic treatment. But the effect of
such a treatment could be even detrimental if stroke
patients suffer from multiple small vessel lesions ori-
ginally caused by BBB leakage.
Moreover, one has to ask what is the main difference
between SHRSP and controls? Do control rats develop
the pathology of CSVD cascade only later on or in other
words: Are the vascular risk factors in SHRSP some kind
of accelerator for a pathology caused in controls simply
by aging? We also found an increasing number of stases
in older control rats correlating with vascular changes
in the kidney comparable to the findings in SHRSP.
Control rats exhibit limited mini- and microbleeds andso far no one exemplar developed overt ischemic le-
sions. Thus, it is obvious that the vascular system also
in control rats undergoes an age-dependent impairment.
But probably only a very little fraction of them will de-
velop the typical pathological cascade of CSVD we have
found in SHRSP.
The genetically most related population to SHRSP
is the SHRSR. The risk profile also includes chronic
arterial hypertension with disturbances of renal factors
[18]. However, for the development of spontaneous
strokes there are additional factors necessary making
the difference to SHRSP which are in the end inbred
SHR carrying the full risk profile for the pathological
cascade leading to stroke.
Thus, besides aging and vascular risk factors we sup-
pose that CSVD pathology needs a certain combination
of genetic risk factors and is in its development posi-
tively or negatively influenced by lifestyle. In this regard
it is very important to mention that the incidence and
development of overt infarcts in SHRSP can be heavily
promoted by a high salt diet. Moreover, an application
of a salt-loaded diet induces an abrupt malign increase
of the arterial blood pressure, associated with forced
vessel wall ruptures leading to an extended breakdown
of the BBB with associated cerebral edema and large
primary intracerebral hemorrhages [5,19,20,38]. Thus,
high salt uptake not only accelerates the pathological
cascade but also dramatically modulates the course of
CSVD in SHRSP.
Concluding, the conglomerate of vascular and genetic
risk factors in SHRSP obviously favors an initially small
and insidious age-dependent developing of endothelial
injuries leading to an increasing BBB leakage. The vascu-
lar system seems to react with a restricted coagulation
which causes stases of erythrocytes as a rather byproduct.
It is a challenge for modern imaging diagnostics to
detect these early vascular changes to selectively recognize
patients with an elevated vascular risk profile. One
approach could be the development of new, especially
renal biomarkers in blood and urine. Therefore, in
SHRSP we have just started to investigate urine con-
centrations of the kidney-injury-molecule-1 (KIM-1),
marking a renal tubular damage [39]. We are inter-
ested whether this marker also indicates the stages of
renal and cerebral vascular changes. Modern imaging
is surely the second approach for directly visualizing
early vascular changes. Contrast-enhanced magnetic
resonance microangiography (CE-μMRA; [40]) opens
the avenue for new MRI sequences having the cap-
acity to detect tiny vascular events like stases, vessel-
wall-adherent coagulation or plasma leakage. A better
diagnostic will give the basis for a specifically adapted
treatment of patients developing dementia and stroke-
like symptoms from CSVD.
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cerebral vascular diseases is the promotion of healthy
campaigns persuading people to prevent the age driven
progress of CSVD under the slogan:
More physical activity, less salt, no smoking!
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